On Tuesday, November 12, 2019, from 4:00 PM to 4:30 PM, we learned about the CureDuchenne Biobank, which launched at our 2019 FUTURES national conference and will continue collecting samples at select CureDuchenne events around the country.
Topics and their respective speakers, include:
- An Introduction to our CureDuchenne Biobank and why we created it | Debra Miller, CEO & Founder, CureDuchenne
- An overview of the Biospecimen collection and the impact your participation can make to Duchenne research | Tahseen Mozaffar, MD, Professor & Interim Chair, Neurology and Chair, Institutional Review Board. University of California, Irvine
- An example for how your biospecimen can be used to support immunological studies for Duchenne | Armando Villalta, PhD, Assistant Professor Physiology & Biophysics. School of Medicine, University of California, Irvine
- Upcoming opportunities and contact information | Romina Foster-Bonds, Director of Programs, CureDuchenne